540737 Stock Overview
Shree Ganesh Remedies Limited engages in the research, development, manufacture, and sale of pharmaceutical drug intermediates and fine chemicals for pharmaceutical industry in India.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 6/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 540737 from our risk checks.
Shree Ganesh Remedies Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹663.75 |
52 Week High | ₹736.00 |
52 Week Low | ₹228.55 |
Beta | 0.29 |
1 Month Change | -5.14% |
3 Month Change | -4.01% |
1 Year Change | 182.81% |
3 Year Change | 137.80% |
5 Year Change | 1,376.98% |
Change since IPO | 2,592.14% |
Recent News & Updates
Recent updates
Shareholder Returns
540737 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -1.9% | 2.4% | 2.3% |
1Y | 182.8% | 65.0% | 48.6% |
Return vs Industry: 540737 exceeded the Indian Pharmaceuticals industry which returned 65% over the past year.
Return vs Market: 540737 exceeded the Indian Market which returned 48.6% over the past year.
Price Volatility
540737 volatility | |
---|---|
540737 Average Weekly Movement | 4.7% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.6% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 540737 has not had significant price volatility in the past 3 months.
Volatility Over Time: 540737's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 110 | Chandulal Kothia | https://www.ganeshremedies.com |
Shree Ganesh Remedies Limited engages in the research, development, manufacture, and sale of pharmaceutical drug intermediates and fine chemicals for pharmaceutical industry in India. Its pharmaceutical drug intermediates comprise anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, anti-fungal, anti-histamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary pharmaceutical ingredient intermediates. The company also offers fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals, including hexamethylendichloride, octamethylendiamine, and suberonitrile for pharmaceutical, agricultural, and chemical applications.
Shree Ganesh Remedies Limited Fundamentals Summary
540737 fundamental statistics | |
---|---|
Market cap | ₹8.47b |
Earnings (TTM) | ₹219.84m |
Revenue (TTM) | ₹1.17b |
38.8x
P/E Ratio7.3x
P/S RatioIs 540737 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
540737 income statement (TTM) | |
---|---|
Revenue | ₹1.17b |
Cost of Revenue | ₹603.53m |
Gross Profit | ₹570.83m |
Other Expenses | ₹350.99m |
Earnings | ₹219.84m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 17.11 |
Gross Margin | 48.61% |
Net Profit Margin | 18.72% |
Debt/Equity Ratio | 38.3% |
How did 540737 perform over the long term?
See historical performance and comparison